Haoxi Health Technology Limited (HAO)
(Real Time Quote from BATS)
$6.26 USD
-1.08 (-14.71%)
Updated May 1, 2024 10:22 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HAO 6.26 -1.08(-14.71%)
Will HAO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for HAO based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for HAO
Haoxi Health Technology Ltd trading halted, volatility trading pause
BKKT, CETX and SWVL among mid-day movers
MAX, KUKE among major communication services gainers; WBD, ATUS among losers
12 Communication Services Stocks Moving In Thursday's Intraday Session
Top 3 Tech And Telecom Stocks Which Could Rescue Your Portfolio This Quarter